rs199701329

Variant summary

Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_001369268.1(ACAN):​c.230G>A​(p.Arg77His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00134 in 1,614,026 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0013 ( 1 hom. )

Consequence

ACAN
NM_001369268.1 missense

Scores

2
17

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:6

Conservation

PhyloP100: 1.13
Variant links:
Genes affected
ACAN (HGNC:319): (aggrecan) This gene is a member of the aggrecan/versican proteoglycan family. The encoded protein is an integral part of the extracellular matrix in cartilagenous tissue and it withstands compression in cartilage. Mutations in this gene may be involved in skeletal dysplasia and spinal degeneration. Multiple alternatively spliced transcript variants that encode different protein isoforms have been observed in this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0048683584).
BP6
Variant 15-88838822-G-A is Benign according to our data. Variant chr15-88838822-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 446080.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Benign=1, Uncertain_significance=2}. Variant chr15-88838822-G-A is described in Lovd as [Likely_benign]. Variant chr15-88838822-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00135 (205/152320) while in subpopulation NFE AF= 0.00176 (120/68024). AF 95% confidence interval is 0.00151. There are 0 homozygotes in gnomad4. There are 118 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 205 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ACANNM_001369268.1 linkuse as main transcriptc.230G>A p.Arg77His missense_variant 3/19 ENST00000560601.4 NP_001356197.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ACANENST00000560601.4 linkuse as main transcriptc.230G>A p.Arg77His missense_variant 3/193 NM_001369268.1 ENSP00000453581 P1

Frequencies

GnomAD3 genomes
AF:
0.00135
AC:
205
AN:
152202
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000196
Gnomad ASJ
AF:
0.000576
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00631
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00176
Gnomad OTH
AF:
0.00143
GnomAD3 exomes
AF:
0.00154
AC:
385
AN:
249238
Hom.:
1
AF XY:
0.00162
AC XY:
219
AN XY:
135230
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000261
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000261
Gnomad FIN exome
AF:
0.00683
Gnomad NFE exome
AF:
0.00186
Gnomad OTH exome
AF:
0.00182
GnomAD4 exome
AF:
0.00134
AC:
1962
AN:
1461706
Hom.:
1
Cov.:
32
AF XY:
0.00131
AC XY:
954
AN XY:
727136
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.000268
Gnomad4 ASJ exome
AF:
0.0000383
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000174
Gnomad4 FIN exome
AF:
0.00657
Gnomad4 NFE exome
AF:
0.00137
Gnomad4 OTH exome
AF:
0.000944
GnomAD4 genome
AF:
0.00135
AC:
205
AN:
152320
Hom.:
0
Cov.:
32
AF XY:
0.00158
AC XY:
118
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.000241
Gnomad4 AMR
AF:
0.000196
Gnomad4 ASJ
AF:
0.000576
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00631
Gnomad4 NFE
AF:
0.00176
Gnomad4 OTH
AF:
0.00142
Alfa
AF:
0.00131
Hom.:
1
Bravo
AF:
0.000740
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00130
AC:
11
ExAC
AF:
0.00183
AC:
222
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00120
EpiControl
AF:
0.00142

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:6
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:3
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpNov 27, 2023- -
Likely benign, no assertion criteria providedclinical testingLaboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)-- -
Likely benign, criteria provided, single submitterclinical testingCenter for Pediatric Genomic Medicine, Children's Mercy Hospital and ClinicsSep 15, 2017- -
Uncertain significance, criteria provided, single submitterclinical testingGeneDxApr 05, 2021In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsApr 11, 2023The c.230G>A (p.R77H) alteration is located in exon 3 (coding exon 2) of the ACAN gene. This alteration results from a G to A substitution at nucleotide position 230, causing the arginine (R) at amino acid position 77 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
ACAN-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesApr 02, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
not specified Benign:1
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Osteochondritis dissecans Benign:1
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Benign
0.16
.;T;.;T;.;.;T
Eigen
Benign
-0.19
Eigen_PC
Benign
-0.074
FATHMM_MKL
Benign
0.45
N
LIST_S2
Benign
0.81
T;T;T;T;T;T;.
M_CAP
Benign
0.010
T
MetaRNN
Benign
0.0049
T;T;T;T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.14
.;N;.;.;N;N;N
MutationTaster
Benign
1.0
N;N;N;N;N
PrimateAI
Benign
0.33
T
PROVEAN
Uncertain
-2.6
.;D;.;D;D;D;D
REVEL
Benign
0.15
Sift
Benign
0.12
.;T;.;T;T;T;T
Sift4G
Benign
0.46
.;T;T;T;T;T;T
Polyphen
0.016
.;.;.;B;.;.;.
Vest4
0.23, 0.30, 0.10, 0.29, 0.23, 0.26
MVP
0.19
MPC
0.25
ClinPred
0.031
T
GERP RS
4.8
Varity_R
0.081
gMVP
0.57

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs199701329; hg19: chr15-89382053; API